Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Feleke Tilahun"'
Autor:
Saskia van Henten, Fentaw Bialfew, Seid Hassen, Feleke Tilahun, Johan van Griensven, Seid Getahun Abdela
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 8, Iss 8, p 414 (2023)
Cutaneous leishmaniasis (CL) is common in Ethiopia, but the national guideline does not offer specific treatment recommendations. Consequently, different treatment regimens are used in the country, without quality evidence. In Boru Meda Hospital, sod
Externí odkaz:
https://doaj.org/article/973f8ff922cd4a008b3bed33fd851476
Autor:
Feleke Tilahun Zewdu, Asressie Molla Tessema, Aregash Abebayehu Zerga, Saskia van Henten, Saba Maria Lambert
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 9, p e0010578 (2022)
BackgroundCutaneous leishmaniasis (CL) is generally caused by Leishmania aethiopica in Ethiopia, and is relatively hard to treat. Sodium stibogluconate (SSG) is the only routinely and widely available antileishmanial treatment, and can be used system
Externí odkaz:
https://doaj.org/article/bbbb24ce02064d69ba49cedc3a8b883f
Autor:
Saskia van Henten, Annisa Befekadu Tesfaye, Seid Getahun Abdela, Feleke Tilahun, Helina Fikre, Jozefien Buyze, Mekibib Kassa, Lieselotte Cnops, Myrthe Pareyn, Rezika Mohammed, Florian Vogt, Ermias Diro, Johan van Griensven
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 5, p e0009460 (2021)
BackgroundCutaneous leishmaniasis (CL) in Ethiopia, caused by Leishmania aethiopica, is often severe and hard to treat compared to CL caused by other species elsewhere. Miltefosine is the only oral anti-leishmanial drug, with a favorable side-effect
Externí odkaz:
https://doaj.org/article/fc120820195d4bb4874b87181a025cc7
Autor:
Seid Getahun Abdela, Saskia van Henten, Seid Hassen Abegaz, Fentaw Bialfew Bayuh, Feleke Tilahun Zewdu, Fentaw Tadese Berhe, Johan van Griensven
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 14, Iss 9, p e0008702 (2020)
BackgroundAlthough Ethiopia eliminated leprosy as public health problem 20 years ago, still more than 3000 new cases are reported annually. Leprosy related disability affects patients' day to day physical activities and their participation in social
Externí odkaz:
https://doaj.org/article/ab5689c6c352425394ccddd4025f23d1
Autor:
Zewdu, Feleke Tilahun1, Abdela, Seid Getahun2, Takarinda, Kudakwashe C.3, Kamau, Edward Mberu4, van Griensven, Johan5, van Henten, Saskia5
Publikováno v:
Journal of Infection in Developing Countries. 2022 Supplement, Vol. 16, p41S-44S. 4p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bayuh, Fentaw Bialfew, Gelaye, Kassahun Alemu, Dawed, Yeshimebet Ali, Zewdu, Feleke Tilahun, Mengistu, Abdulkerim
Publikováno v:
Ophthalmology Journal (2450-7873); 2023, Vol. 8, p87-93, 7p
Autor:
Wendimagegn Enbiale Yeshaneh, Hannock Tweya, Feleke Tilahun Zewdu, Collins Timire, Johan van Griensven, Fentaw Tadese Berhe, Koku Sisay Tamirat, Ermias Diro, Seid Getahun Abdela
Publikováno v:
The Journal of Infection in Developing Countries. 14:10S-15S
Introduction: Following the recommendation of the Global Leprosy Strategy, Ethiopia targeted to reduce the incidence of new leprosy cases, and the proportion with severe disability (grade 2) from 13.6% in 2016 to < 1% in 2020. This study assessed the
Autor:
Feleke Tilahun Zewdu, Asressie Molla Tessema, Aregash Abebayehu Zerga, Saskia van Henten, Saba Maria Lambert
Publikováno v:
PLoS neglected tropical diseases. 16(9)
Background Cutaneous leishmaniasis (CL) is generally caused by Leishmania aethiopica in Ethiopia, and is relatively hard to treat. Sodium stibogluconate (SSG) is the only routinely and widely available antileishmanial treatment, and can be used syste
Autor:
Feleke Tilahun Zewdu, Seid Getahun Abdela, Kudakwashe C Takarinda, Edward Mberu Kamau, Johan Van Griensven, Saskia Van Henten
Publikováno v:
Journal of infection in developing countries. 16(8.1)
Introduction: Mycetoma is a chronic infection that can affect the skin, subcutaneous tissue, and bone. Although Ethiopia is in the so-called mycetoma belt, very little has been published about the disease in Ethiopia. There are no data about mycetoma